Sarepta Therapeutics
SRPT
#1401
Rank
$12.41 B
Marketcap
$131.38
Share price
-1.02%
Change (1 day)
-11.69%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Operating Margin for Sarepta Therapeutics (SRPT)

Operating Margin as of May 2024 (TTM): -88.19%

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -88.19%. At the end of 2022 the company had an Operating Margin of -68.24%.

Operating Margin history for Sarepta Therapeutics from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-68.24%34.77%
2021-50.64%-44.54%
2020-91.30%-49.11%
2019-179.40%57.16%
2018-114.15%23.21%
2017-92.64%-98.12%
2016-4,920.31%-72%
2015-17,572.55%1181.54%
2014-1,371.21%115.95%
2013-634.95%697.97%
2012-79.57%4.07%
2011-76.46%7.45%
2010-71.16%-19.31%
2009-88.18%6.87%
2008-82.52%-72.62%
2007-301.38%-98.95%
2006-28,608.52%7713.06%
2005-366.16%-93.71%
2004-5,817.95%198.97%
2003-1,945.99%-35.74%
2002-3,028.39%38.83%
2001-2,181.36%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
26.84%-130.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.20%-4.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-149.57% 69.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-108.63% 23.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-195.69% 121.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-77.02%-12.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,886.32% 2,038.93%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.